Real-time enrollment status for this end stage renal disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05786443 |
| Recruiting Status | Recruiting |
| Condition | End Stage Renal Disease |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of March 2, 2026: Clinical trial NCT05786443 is currently recruiting participants. This clinical trial study for end stage renal disease is actively seeking new participants at 2 locations across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05786443 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05786443 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.